AI made execution free. Knowing first is the whole game now.
The advantage goes to whoever is first into the right conversations, most often. Fundz stacks those odds: more of the moments that create demand than anyone else catches, as they happen, matched to who you sell to, with the decision maker to call. Now it answers in Claude too: ask for today’s leads and who to reach, then write the note in the same window. Not a feed. Not a list you rent. A system for being first.
Trusted by
Acquiring Company
Boryeong
Acquired Company
Sanofi
South Chungcheong
ParisBiotechnologyPharmaceuticalBiotechnologyHealth CareMedicalPharmaceuticalDescription
Boryeong has successfully completed the acquisition of Taxotel's global business from Sanofi, enhancing its portfolio of anticancer drugs. The deal, valued at up to 175 million euros, allows Boryeong to produce and supply Taxotel in various markets. With a new long-term contract in place with Lee Pan Pharmaceutical, Boryeong secures a seven-year supply agreement for the Chinese market, representing the largest supply contract in the company's history.
Fundz sees it the moment Boryeong makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
M&A Insights
Based on deal dataFrequently asked
Who acquired Sanofi?
Sanofi was acquired by Boryeong, based in South Chungcheong. The deal was reported on September 22, 2026. Boryeong is a pharmaceutical company focused on developing and producing anticancer drugs. It has gained recognition in the domestic market through its acquisition strategies. Boryeong is privately held and operates in Biotechnology.
When did Boryeong acquire Sanofi?
Boryeong's acquisition of Sanofi was reported on September 22, 2026. Boryeong has successfully completed the acquisition of Taxotel's global business from Sanofi, enhancing its portfolio of anticancer drugs. The deal, valued at up to 175 million euros, allows Boryeong to produce and supply Taxotel in various markets. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Sanofi do?
It is publicly traded (SNY), operating in Biotechnology, and is based in Paris.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.
5 screens from a live account. No signup.